Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06548048

Dietary Supplementation on Fat Oxidation

A Randomized, Double-blind, Parallel Study to Examine the Effects of N-trans-caffeoyl Tyramine and N-trans-feruloyl Tyramine Bioactives on Fat Oxidation in Adult Women With Overweight and Obesity

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Brightseed · Industry
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this pilot study is to evaluate the effects of 4 weeks of daily consumption of encapsulated N-trans-caffeoyl tyramine (NCT) and N-trans-feruloyl tyramine (NFT) at a dose of 120 mg/d on measures of fat oxidation in women with overweight or obesity. The hypothesis is that fat oxidation at rest (measured via indirect calorimetry) and over a 24 h period (measured via d31-palmitic acid stable isotope tracer) will be higher in the group receiving the active study product compared to the control product at the end of the 4-week consumption period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary supplement containing plant derived phenolicsDietary supplement containing plant derived phenolics
DIETARY_SUPPLEMENTMicrocrystaline celluloseMicrocrystaline cellulose (MCC)

Timeline

Start date
2024-07-31
Primary completion
2024-11-05
Completion
2024-12-31
First posted
2024-08-12
Last updated
2024-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06548048. Inclusion in this directory is not an endorsement.